Ani Pharmaceuticals ANIP
NASDAQ ANIP
$72.18 -0.78 (-1.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ani Pharmaceuticals (ANIP) Cost of Revenue (2012 - 2026)

Updated

Ani Pharmaceuticals' Cost of Revenue was $100.16 million in Q2 2026, up 34.2% from $74.62 million a year earlier and up 7.0% from the prior quarter.

Analysis

Ani Pharmaceuticals (ANIP) Cost of Revenue (2012 - 2026) Analysis & Trends

On a trailing twelve-month basis, Ani Pharmaceuticals' Cost of Revenue was $387.4 million through Jun 30, 2026, up 33.1% year-over-year; for FY2025, it was $341.31 million, up 36.4% from FY2024.

  • Cost of Revenue has now increased for six consecutive years, with a five-year compound annual growth rate of 31.4% (FY2020 to FY2025).
  • In earlier years, Cost of Revenue was $250.21 million in FY2024 (+37.8%), $181.51 million in FY2023 (+30.8%), $138.79 million in FY2022 (+37.9%) and $100.61 million in FY2021 (+15.4%).
  • Quarterly Cost of Revenue has moved between $24.41 million (Q3 2021) and $100.27 million (Q4 2025) over five years.
  • Compared with a year earlier, Cost of Revenue has increased for 21 straight quarters, with growth averaging 36.8% over the last eight quarters.
  • The year-over-year growth in Cost of Revenue has ranged between 7.2% (Q4 2022) and 71.5% (Q1 2022) over the last five years.
  • Per Business Quant data, ANIP's Cost of Revenue in the three quarters before Q2 2026 was $93.58 million (Q1 2026), $100.27 million (Q4 2025) and $93.39 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.05 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.29 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.52 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.58 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.09 Bn
10 Ani Pharmaceuticals 1.72 Bn 502.13 Mn 165.89 Mn 100.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 100.16 Mn
Mar 31, 2026 93.58 Mn
Dec 31, 2025 100.27 Mn
Sep 30, 2025 93.39 Mn
Jun 30, 2025 74.62 Mn
Mar 31, 2025 73.04 Mn
Dec 31, 2024 80.28 Mn
Sep 30, 2024 63.08 Mn
Jun 30, 2024 57.70 Mn
Mar 31, 2024 49.16 Mn
Dec 31, 2023 53.42 Mn
Sep 30, 2023 48.10 Mn
Jun 30, 2023 42.28 Mn
Mar 31, 2023 37.71 Mn
Dec 31, 2022 36.33 Mn
Sep 30, 2022 32.89 Mn
Jun 30, 2022 35.29 Mn
Mar 31, 2022 34.27 Mn
Dec 31, 2021 33.90 Mn
Sep 30, 2021 24.41 Mn
API Access

Ani Pharmaceuticals Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=ANIP&period=max&api_key=YOUR_API_KEY